保留器官的根治性膀胱切除术在肿瘤学上是安全的吗?它能提高生活质量吗?

IF 2.8 3区 医学 Q2 ONCOLOGY
Expert Review of Anticancer Therapy Pub Date : 2025-09-01 Epub Date: 2025-07-03 DOI:10.1080/14737140.2025.2525311
Alireza Aminsharifi, Sri Saran Manivasagam, Mohammad Reza Askarpour, Jay D Raman
{"title":"保留器官的根治性膀胱切除术在肿瘤学上是安全的吗?它能提高生活质量吗?","authors":"Alireza Aminsharifi, Sri Saran Manivasagam, Mohammad Reza Askarpour, Jay D Raman","doi":"10.1080/14737140.2025.2525311","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Radical cystectomy in women with bladder cancer traditionally involves removal of reproductive organs, often leading to significant impairment in quality of life. Organ-preserving radical cystectomy (OPRC) has emerged as an alternative approach aimed at maintaining functional outcomes without compromising oncological safety.</p><p><strong>Methods: </strong>This systematic review evaluates current evidence on oncological, surgical, and functional outcomes of OPRC. A comprehensive literature search was conducted using the PubMed, Scopus, and Cochrane databases up to April 2025. Studies were assessed for methodological quality and risk of bias.</p><p><strong>Results: </strong>Fifteen studies (946 female patients) were included in the review. Data on patient selection criteria, operative parameters, recurrence, survival, continence, and sexual outcomes were discussed.</p><p><strong>Conclusion: </strong>OPRC is a safe and effective option for selected women with organ-confined disease. It offers superior functional outcomes and quality of life compared to standard radical cystectomy without compromising oncologic control. Several studies applied strict criteria, including premenopausal, sexually active women with organ-confined (≤T2) disease, away from bladder neck and no genital organ involvement on imaging. However, considerable heterogeneity existed in patient selection and definitions of functional outcomes. Further prospective trials and standardized criteria are warranted. Integrating these findings into practice guidelines could enhance patient-centered care in women undergoing cystectomy.</p><p><strong>Registration: </strong>PROSPERO (CRD420251045355).</p>","PeriodicalId":12099,"journal":{"name":"Expert Review of Anticancer Therapy","volume":" ","pages":"1075-1085"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Is organ preserving radical cystectomy in women oncologically safe and does it improve quality of life?\",\"authors\":\"Alireza Aminsharifi, Sri Saran Manivasagam, Mohammad Reza Askarpour, Jay D Raman\",\"doi\":\"10.1080/14737140.2025.2525311\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Radical cystectomy in women with bladder cancer traditionally involves removal of reproductive organs, often leading to significant impairment in quality of life. Organ-preserving radical cystectomy (OPRC) has emerged as an alternative approach aimed at maintaining functional outcomes without compromising oncological safety.</p><p><strong>Methods: </strong>This systematic review evaluates current evidence on oncological, surgical, and functional outcomes of OPRC. A comprehensive literature search was conducted using the PubMed, Scopus, and Cochrane databases up to April 2025. Studies were assessed for methodological quality and risk of bias.</p><p><strong>Results: </strong>Fifteen studies (946 female patients) were included in the review. Data on patient selection criteria, operative parameters, recurrence, survival, continence, and sexual outcomes were discussed.</p><p><strong>Conclusion: </strong>OPRC is a safe and effective option for selected women with organ-confined disease. It offers superior functional outcomes and quality of life compared to standard radical cystectomy without compromising oncologic control. Several studies applied strict criteria, including premenopausal, sexually active women with organ-confined (≤T2) disease, away from bladder neck and no genital organ involvement on imaging. However, considerable heterogeneity existed in patient selection and definitions of functional outcomes. Further prospective trials and standardized criteria are warranted. Integrating these findings into practice guidelines could enhance patient-centered care in women undergoing cystectomy.</p><p><strong>Registration: </strong>PROSPERO (CRD420251045355).</p>\",\"PeriodicalId\":12099,\"journal\":{\"name\":\"Expert Review of Anticancer Therapy\",\"volume\":\" \",\"pages\":\"1075-1085\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Anticancer Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/14737140.2025.2525311\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Anticancer Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737140.2025.2525311","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/3 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言:膀胱癌妇女的根治性膀胱切除术传统上包括切除生殖器官,通常导致生活质量的显著损害。器官保留根治性膀胱切除术(OPRC)已成为一种旨在维持功能结果而不影响肿瘤安全性的替代方法。方法:本系统综述评估了目前关于OPRC的肿瘤、外科和功能结果的证据。使用PubMed, Scopus和Cochrane数据库进行了全面的文献检索,截止到2025年4月。评估研究的方法学质量和偏倚风险。结果:15项研究(946例女性患者)纳入本综述。讨论了患者选择标准、手术参数、复发、生存、尿失禁和性结局的数据。结论:OPRC是一种安全有效的选择,适用于特定的女性器官局限性疾病。与标准根治性膀胱切除术相比,它提供了更好的功能结果和生活质量,而不影响肿瘤控制。一些研究采用了严格的标准,包括绝经前、性活跃、器官受限(≤T2)疾病、远离膀胱颈部、无生殖器官受累的女性。然而,在患者选择和功能结局的定义上存在相当大的异质性。进一步的前瞻性试验和标准化标准是必要的。将这些发现纳入实践指南可以加强以患者为中心的妇女膀胱切除术护理。报名:普洛斯彼罗(CRD420251045355)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Is organ preserving radical cystectomy in women oncologically safe and does it improve quality of life?

Introduction: Radical cystectomy in women with bladder cancer traditionally involves removal of reproductive organs, often leading to significant impairment in quality of life. Organ-preserving radical cystectomy (OPRC) has emerged as an alternative approach aimed at maintaining functional outcomes without compromising oncological safety.

Methods: This systematic review evaluates current evidence on oncological, surgical, and functional outcomes of OPRC. A comprehensive literature search was conducted using the PubMed, Scopus, and Cochrane databases up to April 2025. Studies were assessed for methodological quality and risk of bias.

Results: Fifteen studies (946 female patients) were included in the review. Data on patient selection criteria, operative parameters, recurrence, survival, continence, and sexual outcomes were discussed.

Conclusion: OPRC is a safe and effective option for selected women with organ-confined disease. It offers superior functional outcomes and quality of life compared to standard radical cystectomy without compromising oncologic control. Several studies applied strict criteria, including premenopausal, sexually active women with organ-confined (≤T2) disease, away from bladder neck and no genital organ involvement on imaging. However, considerable heterogeneity existed in patient selection and definitions of functional outcomes. Further prospective trials and standardized criteria are warranted. Integrating these findings into practice guidelines could enhance patient-centered care in women undergoing cystectomy.

Registration: PROSPERO (CRD420251045355).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.10
自引率
3.00%
发文量
100
审稿时长
4-8 weeks
期刊介绍: Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信